Astria Therapeutics Inc Preliminary Results From The Phase 1a Clinical Trial Of STAR-0215 Transcript - Thomson StreetEvents

Astria Therapeutics Inc Preliminary Results From The Phase 1a Clinical Trial Of STAR-0215 Transcript

Astria Therapeutics Inc Preliminary Results From The Phase 1a Clinical Trial Of STAR-0215 Transcript - Thomson StreetEvents
Astria Therapeutics Inc Preliminary Results From The Phase 1a Clinical Trial Of STAR-0215 Transcript
Published Dec 15, 2022
15 pages (10218 words) — Published Dec 15, 2022
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Transcript of ATXS.OQ conference call or presentation 15-Dec-22 1:30pm GMT

  
Brief Excerpt:

...Operator Good day, and welcome to the Astria Therapeutics Phase Ia results conference call. (Operator Instructions) Please be advised that today's conference is being recorded. I would now like to hand the conference over to your speaker, Ms. Andrea Matthews, Senior Vice President of Corporate Affairs. Please go ahead. Andrea L. Matthews ...

  
Report Type:

Transcript

Source:
Company:
Astria Therapeutics Inc
Ticker
ATXS.OQ
Time
1:30pm GMT
Format:
PDF Adobe Acrobat
Buy Now

Astria Therapeutics Inc Q3 2023 Earnings Call Transcript – 2023-11-13 – US$ 54.00 – Edited Transcript of ATXS.OQ earnings conference call or presentation 13-Nov-23 1:30pm GMT

Astria Therapeutics Inc to Discuss the OX40 Program STAR-0310 Call Transcript – 2023-10-12 – US$ 54.00 – Edited Transcript of ATXS.OQ conference call or presentation 12-Oct-23 12:30pm GMT

Astria Therapeutics Inc at Jefferies Healthcare Conference Transcript – 2023-06-07 – US$ 54.00 – Edited Transcript of ATXS.OQ presentation 7-Jun-23 6:00pm GMT

Astria Therapeutics Inc Q4 2022 Earnings Call Transcript – 2023-03-22 – US$ 54.00 – Edited Transcript of ATXS.OQ earnings conference call or presentation 22-Mar-23 12:30pm GMT

Astria Therapeutics Inc at Oppenheimer Healthcare Conference (Virtual) Transcript – 2023-03-13 – US$ 54.00 – Edited Transcript of ATXS.OQ presentation 13-Mar-23 5:20pm GMT

Astria Therapeutics Inc at Jefferies London Healthcare Conference Transcript – 2022-11-16 – US$ 54.00 – Edited Transcript of ATXS.OQ presentation 16-Nov-22 7:25am GMT

Astria Therapeutics Inc R&D Day: Update On STAR-0215 And Its Clinical Development For The Prevention Of HAE Attacks Transcript – 2022-09-30 – US$ 54.00 – Edited Transcript of ATXS.OQ conference call or presentation 30-Sep-22 2:30pm GMT

Astria Therapeutics Inc Q3 2021 Earnings Call Transcript – 2021-11-10 – US$ 54.00 – Edited Transcript of ATXS.OQ earnings conference call or presentation 10-Nov-21 1:30pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "Astria Therapeutics Inc Preliminary Results From The Phase 1a Clinical Trial Of STAR-0215 Transcript" Dec 15, 2022. Alacra Store. May 01, 2024. <http://www.alacrastore.com/thomson-streetevents-transcripts/Astria-Therapeutics-Inc-Preliminary-Results-From-The-Phase-1a-Clinical-Trial-Of-STAR-0215-T15423559>
  
APA:
Thomson StreetEvents. (2022). Astria Therapeutics Inc Preliminary Results From The Phase 1a Clinical Trial Of STAR-0215 Transcript Dec 15, 2022. New York, NY: Alacra Store. Retrieved May 01, 2024 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Astria-Therapeutics-Inc-Preliminary-Results-From-The-Phase-1a-Clinical-Trial-Of-STAR-0215-T15423559>
  
US$ 54.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.